The clinico‐radiological paradox in multiple sclerosis revisited
暂无分享,去创建一个
[1] G. Scotti,et al. Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord , 2000, Neuroradiology.
[2] G. Comi,et al. Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.
[3] F. Barkhof,et al. Spinal cord magnetic resonance imaging in suspected multiple sclerosis , 2000, European Radiology.
[4] B. Harding,et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. , 2000, Brain : a journal of neurology.
[5] Marco Rovaris,et al. Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis , 2000, Journal of Neurology.
[6] A. Ciarmiello,et al. Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis. , 2000, Journal of magnetic resonance imaging : JMRI.
[7] J. Warter,et al. MRI in multiple sclerosis of the spinal cord: evaluation of fast short-tan inversion-recovery and spin-echo sequences , 2000, Neuroradiology.
[8] S J Nelson,et al. A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis , 2000, Multiple sclerosis.
[9] R. Bakshi,et al. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. , 2000, Archives of neurology.
[10] I. Vavasour,et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain , 2000, Neurology.
[11] M. Rovaris,et al. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[12] R Stollberger,et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis , 2000, Magnetic resonance in medicine.
[13] P M Matthews,et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.
[14] M Rovaris,et al. Whole brain volume changes in patients with progressive MS treated with cladribine , 2000, Neurology.
[15] R Stollberger,et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[16] G Cutter,et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. , 2000, Multiple sclerosis.
[17] G. Comi,et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.
[18] G. Barker,et al. Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis , 2000, Journal of the Neurological Sciences.
[19] L D Blumhardt,et al. Short‐term ventricular volume changes on serial MRI in multiple sclerosis , 2000, Acta neurologica Scandinavica.
[20] M. Filippi,et al. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose. , 2000, Magnetic resonance imaging.
[21] G J Barker,et al. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.
[22] R. Rudick,et al. Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.
[23] F. Barkhof,et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy , 2001, Journal of the Neurological Sciences.
[24] I. V. Allen,et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.
[25] C. Lucchinetti,et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.
[26] S. Hickman,et al. Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis , 2001, Journal of the Neurological Sciences.
[27] A. Thompson,et al. Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[28] M. Gobbini,et al. Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. , 2001, Archives of neurology.
[29] J. Dehmeshki,et al. Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis , 2001, Magnetic resonance in medicine.
[30] Peter Kapeller,et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study , 2001, Journal of Neurology.
[31] A. Dinçer,et al. Baló's concentric sclerosis: clinical and radiologic features of five cases. , 2001, AJNR. American journal of neuroradiology.
[32] M. Kaps,et al. Induction of sTNF‐R1 and sTNF‐R2 by interferon beta‐1b in correlation with clinical and MRI activity , 2001, Acta neurologica Scandinavica.
[33] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[34] Jerry S. Wolinsky,et al. Ingested IFN-α , 2001, Neurology.
[35] A J Thompson,et al. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow‐up study , 2001, European journal of neurology.
[36] E. Waubant,et al. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS , 2001, Journal of Neuroimmunology.
[37] P. Kramer,et al. MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis , 2001, Neurology.
[38] A. Thompson,et al. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study , 2001, Multiple sclerosis.
[39] M. Filippi,et al. Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis , 2001, Neurology.
[40] G Cutter,et al. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS , 2001, Neurology.
[41] M. Filippi,et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS , 2001, Neurology.
[42] F. Barkhof,et al. Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells , 2001, Journal of Neuroimmunology.
[43] D. Sobel,et al. Predictive value of lesions for relapses in relapsing-remitting multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[44] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.
[45] L. Blumhardt,et al. Inflammation and atrophy in multiple sclerosis: MRI associations with disease course , 2001, Journal of the Neurological Sciences.
[46] R. Rudick,et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.
[47] F Barkhof,et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.
[48] J S Wolinsky,et al. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging , 2001, Multiple sclerosis.
[49] U Klose,et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.
[50] R. Zivadinov,et al. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis , 2001, Neuroradiology.
[51] E. Melhem,et al. Accuracy for detection of simulated lesions: comparison of fluid-attenuated inversion-recovery, proton density--weighted, and T2-weighted synthetic brain MR imaging. , 2001, AJR. American journal of roentgenology.
[52] S. Lingawi,et al. A comparison of conventional spin‐echo and fast spin‐echo in the detection of multiple sclerosis , 2001, Journal of magnetic resonance imaging : JMRI.
[53] A. J. Thompson,et al. T1 hypointensity of the spinal cord in multiple sclerosis , 2001, Journal of Neurology.
[54] G J Barker,et al. Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions , 2001, Multiple sclerosis.
[55] F. Barkhof,et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. , 2001, Brain : a journal of neurology.
[56] J. Dehmeshki,et al. Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups , 2001, Journal of the Neurological Sciences.
[57] G. Comi,et al. Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes” , 2001, Neurology.
[58] F. Barkhof,et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker , 2001, Neurology.
[59] C R Guttmann,et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. , 2001, Archives of neurology.
[60] D. Li,et al. Randomized controlled trial of interferon-beta-1a in secondary progressive MS , 2001, Neurology.
[61] A. Rojiani,et al. Pathognomonic MR imaging findings in Balo concentric sclerosis. , 2001, AJNR. American journal of neuroradiology.
[62] Massimo Filippi,et al. European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.
[63] M. Filippi,et al. Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis , 2001, Journal of the Neurological Sciences.
[64] R. Bakshi,et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.
[65] Jesús Pujol,et al. The Effect of Medial Frontal and Posterior Parietal Demyelinating Lesions on Stroop Interference , 2001, NeuroImage.
[66] A J Thompson,et al. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[67] J. Wolinsky,et al. Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS. , 2001, Neurology.
[68] J S Wolinsky,et al. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center. , 2001, Multiple sclerosis.
[69] F Barkhof,et al. Optimizing the association between disability and biological markers in MS , 2001, Neurology.
[70] G J Barker,et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.
[71] G. Comi,et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[72] P. Rossini,et al. Patterns of Cognitive Impairment in Secondary Progressive Stable Phase of Multiple Sclerosis: Correlations with MRI Findings , 2001, European Neurology.
[73] A. Destée,et al. Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. , 2001, Brain : a journal of neurology.
[74] F. Barkhof,et al. Hypointense Lesions on T 1-Weighted Spin-Echo Magnetic Resonance Imaging Relation to Clinical Characteristics in Subgroups of Patients With Multiple Sclerosis , 2001 .
[75] P. Livrea,et al. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study , 2001, Journal of the Neurological Sciences.
[76] C. Good,et al. A modified protocol to improve the detection of enhancing brain and spinal cord leasions in multiple sclerosis , 2001, Journal of Neurology.
[77] P S Morgan,et al. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[78] A. Thompson,et al. Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI , 2001, Journal of neurology, neurosurgery, and psychiatry.
[79] F. Barkhof,et al. TNFα production by CD4+ T cells predicts long-term increase in lesion load on MRI in MS , 2001, Neurology.
[80] J K Udupa,et al. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[81] L G Nyúl,et al. Relapsing-remitting Multiple Sclerosis: Fractional Volumetric Analysis of Gray Matter and White Matter , 2000 .
[82] C. Mainero,et al. Correlates of MS disability assessed in vivo using aggregates of MR quantities , 2001, Neurology.
[83] M Cercignani,et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.
[84] D. Prayer,et al. Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis. , 2001, Neuropediatrics.
[85] R. Bakshi,et al. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. , 2001, Archives of neurology.
[86] L D Blumhardt,et al. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis , 2001, Acta neurologica Scandinavica.
[87] G. Comi,et al. Modelling new enhancing MRI lesion counts in multiple sclerosis , 2001, Multiple sclerosis.
[88] G Cazzato,et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[89] F. Barkhof,et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. , 2001, Archives of neurology.
[90] H. Weiner,et al. Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS , 2001, Journal of Neuroimmunology.
[91] M. Rovaris,et al. Effects of seasons on magnetic resonance imaging–measured disease activity in patients with multiple sclerosis , 2001, Annals of neurology.
[92] A. Thompson,et al. T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. , 2001, Brain : a journal of neurology.
[93] L. Krupp,et al. Cognitive Dysfunction Lateralizes With NAA in Multiple Sclerosis , 2001, Applied neuropsychology.
[94] M Rovaris,et al. Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. , 2001, AJNR. American journal of neuroradiology.
[95] R. Kikinis,et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. , 2001, Archives of neurology.
[96] F. Lublin,et al. Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. , 2001, Archives of neurology.
[97] P M Matthews,et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.
[98] Massimo Filippi,et al. Improved interobserver agreement for visual detection of active T2 lesions on serial MR scans in multiple sclerosis using image registration , 2001, Journal of Neurology.
[99] F. Barkhof,et al. Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets , 2001, Journal of neurology, neurosurgery, and psychiatry.
[100] N. Richert. Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". , 2002, Neurology.